Evaluating the Effectiveness of the GILL eHealth Intervention to Improve Physical Health and Lifestyle Behaviours in Patients With Severe Mental Illness (GILL)
Primary Purpose
Severe Mental Disorder, Metabolic Syndrome, Lifestyle
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
GILL eHealth
Sponsored by
About this trial
This is an interventional treatment trial for Severe Mental Disorder
Eligibility Criteria
Inclusion Criteria:
- Meet the criteria of severe mental illness
- Aged from 18 to 65 years
- Body mass index (BMI) ≥ 27
- Access and ability to use internet and mobile device
- Able and willing to sign informed consent
Exclusion Criteria:
- Contra-indications (to be assessed by the treating physician/psychiatrist) for participation due to acute psychiatric crisis or severe somatic diseases
- Subjects with a cognitive impairment sufficient to interfere with their ability to provide informed consent, complete study questionnaires, or participate in the intervention
- Pregnant or breastfeeding women at the time of inclusion
- Subject not able to communicate in the Dutch language
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
GILL eHealth module
Care as usual
Arm Description
Patients will perform the GILL eHealth. This eHealth contains two modules focusing on systematic somatic screening and lifestyle behaviors.
Patients will receive usual care and have unrestricted access to mental care and treatment.
Outcomes
Primary Outcome Measures
Metabolic Syndrome Severity Score (MSSS)
The MSSS includes the components sex, age, ethnicity, systolic blood pressure (mmHg), waistline circumference (cm), high-density lipoprotein, triglycerides and fasting blood glucose. A lower score is considered better.
Secondary Outcome Measures
Weight (kg)
Weight is an indication for physical health.
Length (m)
Length will be measured to calculate the BMI.
Body Mass Index (kg/m2)
Body Mass Index (BMI) will be determined using the measured weight and length. A BMI between 18.5 and 25 is considered healthy.
Diastolic blood pressure (mmHg)
A healthy score of the diastolic blood pressure lies between 60 and 80 mmHg.
Lipid profiles (mmol/l)
LDL and total cholesterol will be determined. For the LDL a score below 3,0 mmol/l is considered good for healthy participants, participants with additional risks for cardiovascular diseases should have a score below 2.6 mmol/l, and for participants with a cardiovascular disease the score should be below 1.8 mmol/l. Overall, a lower LDL score is considered better. For the total cholesterol a score below 5.0 mmol/l is considered healthy.
HbA1c (mmol/l)
HbA1c is a measurement outcome to determine blood glucose. A score below 53 is considered healthy.
Six-minute walk test (6MWT)
The 6MWT is a measurement to assess physical fitness. It measures the walking distance in 6 minutes. A higher score indicates a longer distance walked and a better physical fitness.
International Physical Activity Questionnaire Short Form (IPAQ-SF)
The IPAQ-SF is a 10-item self-report questionnaire where participants recall the number of days and minutes of vigorous activity, moderate activity, walking and sitting time, over the past 7 days. A higher score indicates more physical activity.
Visual Analogue Scale (VAS)
The VAS will be used to determine the perceived physical health, physical activity and healthy eating of the past 4 weeks on a scale from 0-100. A higher score is considered better.
Short Form-12
This is a generic, reliable and validated instrument to assess quality of life, containing 12 items derived from the Short Form 36 questionnaire. Physical and mental quality of life will be measured using the physical and mental component summary of the SF-12, respectively. A higher scores indicates a better health status.
Questionnaire about Processes of Recovery (QPR)
The QPR is a self-report 15-item questionnaire with a score range of 0-60 (QPR total). Higher scores are indicative of recovery.
Health of the Nation Outcome Scale (HoNOS)
The HoNOS is a clinician-rated instrument comprising twelve items on four domains (behavioral problems, organic problems, psychological symptoms, social problems), each item ranging from 0 (no problems) to 4 (severe problems). A lower score is considered better.
Patient Activation Measure (PAM-13)
The questionnaire assesses the participants' self-reported knowledge, skills and confidence for health-related self-efficacy. A higher score is considered better.
Full Information
NCT ID
NCT05533749
First Posted
August 25, 2022
Last Updated
September 8, 2022
Sponsor
Amsterdam UMC, location VUmc
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
1. Study Identification
Unique Protocol Identification Number
NCT05533749
Brief Title
Evaluating the Effectiveness of the GILL eHealth Intervention to Improve Physical Health and Lifestyle Behaviours in Patients With Severe Mental Illness
Acronym
GILL
Official Title
Improving Physical Health and Lifestyle Behaviors in Patients With Serious Mental Illness: a Cluster Randomized Controlled Trial on the Effectiveness of the Nurse-led GILL eHealth Intervention
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2023 (Anticipated)
Primary Completion Date
October 31, 2025 (Anticipated)
Study Completion Date
October 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Amsterdam UMC, location VUmc
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to evaluate the effectiveness of the nurse-led GILL (Gezondheid in Lichaam en Leefstijl) eHealth intervention in patients with serious mental illness (SMI), compared to usual care. Expected is that the GILL eHealth intervention will be more effective than usual care in improving physical health and lifestyle behaviors. To evaluate this, we will perform a cluster randomized controlled trial with an embedded process evaluation of the implementation of the GILL intervention. 246 adult patients with serious mental illness and a body mass index of 27 or higher (overweight/obesity) will be included. The GILL eHealth intervention consists of two complementary modules for (a) somatic screening and (b) lifestyle promotion, resulting in a personalized somatic treatment and lifestyle plan. Trained mental health nurses and clinical nurse specialists will implement the intervention within the multidisciplinary treatment context, and will guide and support the patients in the promotion of their somatic health, including cardiometabolic risk management. The intervention will be compared to usual care, which includes treatment according to national guidelines. The outcome measures will be metabolic syndrome severity (primary), fitness, physical activity, lifestyle behaviors, quality of life, recovery, psychosocial functioning, health related self-efficacy and health care utilization after 1 year. The process evaluation focuses on the feasibility of the eHealth intervention, its acceptability for patients and health care providers (mainly mental health nurses and clinical nurse specialists), and barriers/facilitators to implementation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Severe Mental Disorder, Metabolic Syndrome, Lifestyle, Somatic Screening, eHealth
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomized to the intervention group or to care as usual. In the intervention group patients will receive the GILL eHealth intervention focusing on systematic somatic screening and lifestyle behaviours.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
246 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
GILL eHealth module
Arm Type
Experimental
Arm Description
Patients will perform the GILL eHealth. This eHealth contains two modules focusing on systematic somatic screening and lifestyle behaviors.
Arm Title
Care as usual
Arm Type
No Intervention
Arm Description
Patients will receive usual care and have unrestricted access to mental care and treatment.
Intervention Type
Device
Intervention Name(s)
GILL eHealth
Intervention Description
The aim of the successfully pilot-tested GILL eHealth intervention is to support mental health nurses and clinical nurse specialists in structured somatic screening and lifestyle promotion. The GILL eHealth intervention consists of two parts. Part one is OurGILL which focuses on systematic somatic screening and provides an overview of all somatic abnormalities. It promotes the prevention, early recognition and treatment of somatic problems. The second part is MyGILL. It provides the basis for drawing up a personalized lifestyle plan. The result of MyGILL is an overview of the performance of patients in different lifestyle areas. The eHealth intervention consists of an individual internet environment and is also supported by an app for mobile devices.
Primary Outcome Measure Information:
Title
Metabolic Syndrome Severity Score (MSSS)
Description
The MSSS includes the components sex, age, ethnicity, systolic blood pressure (mmHg), waistline circumference (cm), high-density lipoprotein, triglycerides and fasting blood glucose. A lower score is considered better.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Weight (kg)
Description
Weight is an indication for physical health.
Time Frame
12 months
Title
Length (m)
Description
Length will be measured to calculate the BMI.
Time Frame
1 measurement
Title
Body Mass Index (kg/m2)
Description
Body Mass Index (BMI) will be determined using the measured weight and length. A BMI between 18.5 and 25 is considered healthy.
Time Frame
12 months
Title
Diastolic blood pressure (mmHg)
Description
A healthy score of the diastolic blood pressure lies between 60 and 80 mmHg.
Time Frame
12 months
Title
Lipid profiles (mmol/l)
Description
LDL and total cholesterol will be determined. For the LDL a score below 3,0 mmol/l is considered good for healthy participants, participants with additional risks for cardiovascular diseases should have a score below 2.6 mmol/l, and for participants with a cardiovascular disease the score should be below 1.8 mmol/l. Overall, a lower LDL score is considered better. For the total cholesterol a score below 5.0 mmol/l is considered healthy.
Time Frame
12 months
Title
HbA1c (mmol/l)
Description
HbA1c is a measurement outcome to determine blood glucose. A score below 53 is considered healthy.
Time Frame
12 months
Title
Six-minute walk test (6MWT)
Description
The 6MWT is a measurement to assess physical fitness. It measures the walking distance in 6 minutes. A higher score indicates a longer distance walked and a better physical fitness.
Time Frame
12 months
Title
International Physical Activity Questionnaire Short Form (IPAQ-SF)
Description
The IPAQ-SF is a 10-item self-report questionnaire where participants recall the number of days and minutes of vigorous activity, moderate activity, walking and sitting time, over the past 7 days. A higher score indicates more physical activity.
Time Frame
12 months
Title
Visual Analogue Scale (VAS)
Description
The VAS will be used to determine the perceived physical health, physical activity and healthy eating of the past 4 weeks on a scale from 0-100. A higher score is considered better.
Time Frame
12 months
Title
Short Form-12
Description
This is a generic, reliable and validated instrument to assess quality of life, containing 12 items derived from the Short Form 36 questionnaire. Physical and mental quality of life will be measured using the physical and mental component summary of the SF-12, respectively. A higher scores indicates a better health status.
Time Frame
12 months
Title
Questionnaire about Processes of Recovery (QPR)
Description
The QPR is a self-report 15-item questionnaire with a score range of 0-60 (QPR total). Higher scores are indicative of recovery.
Time Frame
12 months
Title
Health of the Nation Outcome Scale (HoNOS)
Description
The HoNOS is a clinician-rated instrument comprising twelve items on four domains (behavioral problems, organic problems, psychological symptoms, social problems), each item ranging from 0 (no problems) to 4 (severe problems). A lower score is considered better.
Time Frame
12 months
Title
Patient Activation Measure (PAM-13)
Description
The questionnaire assesses the participants' self-reported knowledge, skills and confidence for health-related self-efficacy. A higher score is considered better.
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Demographics
Description
Age, gender, ethnicity, marital status, education level, employment status, psychiatric diagnoses, diagnosesof somatic diseases, current smoking status, number of years receiving mental care, and medication use.
Time Frame
12 months
Title
Treatment Inventory of Costs in Patients with psychiatric disorders (TIC-P)
Description
The TIC-P is a validated questionnaire designed for self-report in adult patients with a mental disorder to assess their utilization of the medical health care costs. The TIC-P items that will be used include 14 structured questions on the volume of medical costs, e.g. ambulatory services, private practice, and general practitioner. A higher outcome value means more health care costs.
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Meet the criteria of severe mental illness
Aged from 18 to 65 years
Body mass index (BMI) ≥ 27
Access and ability to use internet and mobile device
Able and willing to sign informed consent
Exclusion Criteria:
Contra-indications (to be assessed by the treating physician/psychiatrist) for participation due to acute psychiatric crisis or severe somatic diseases
Subjects with a cognitive impairment sufficient to interfere with their ability to provide informed consent, complete study questionnaires, or participate in the intervention
Pregnant or breastfeeding women at the time of inclusion
Subject not able to communicate in the Dutch language
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Meike M Hoogervorst
Phone
+31629680823
Email
m.m.hoogervorst@amsterdamumc.nl
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be intellectual property of the research team, and will be available for others in case of requests after publication of the results according to privacy regulations.
Learn more about this trial
Evaluating the Effectiveness of the GILL eHealth Intervention to Improve Physical Health and Lifestyle Behaviours in Patients With Severe Mental Illness
We'll reach out to this number within 24 hrs